Reduced spinal microglial activation and neuropathic pain after nerve injury in mice lacking all three nitric oxide synthases

Molecular Pain

Volumn 7, Issue , 2011, Pages

  Kuboyama, Kazuya ^a   Tsuda, Makoto ^a   Tsutsui, Masato ^b   Toyohara, Yumiko ^c   Tozaki Saitoh, Hidetoshi ^a   Shimokawa, Hiroaki ^d   Yanagihara, Nobuyuki ^c   Inoue, Kazuhide ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROTEIN TYROSINE KINASE; PURINERGIC P2X4 RECEPTOR; TOLL LIKE RECEPTOR 6; NITRIC OXIDE SYNTHASE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EVOKED RESPONSE; GENE; GENE EXPRESSION; INDUCIBLE NITRIC OXIDE SYNTHASE GENE; MALE; MICROGLIA; MOUSE; NERVE STIMULATION; NEURONAL NITRIC OXIDE SYNTHASE GENE; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NERVE INJURY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; SPINAL NERVE; TACTILE ALLODYNIA; WILD TYPE; ANIMAL; ANIMAL BEHAVIOR; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; HYPERALGESIA; INFLAMMATION; INJURY; METABOLISM; NEURALGIA; PATHOLOGY; SPINAL CORD; TEMPERATURE;

ANIMALS; BEHAVIOR, ANIMAL; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; HYPERALGESIA; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-6; MACROPHAGE-1 ANTIGEN; MALE; MICE; MICROGLIA; NEURALGIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTORS, PURINERGIC P2X4; RNA, MESSENGER; SPINAL CORD; SPINAL NERVES; SRC-FAMILY KINASES; TEMPERATURE; TOLL-LIKE RECEPTOR 4;

EID: 79960558104     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-7-50     Document Type: Article

References (40)

1. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964. 10.1016/S0140-6736(99)01307-0, 10371588.
2. Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 2005, 28:101-107. 10.1016/j.tins.2004.12.002, 15667933.
3. Tanga FY, Nutile-McMenemy N, DeLeo JA. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci USA 2005, 102:5856-5861. 10.1073/pnas.0501634102, 556308, 15809417.
4. Inoue K. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol Ther 2006, 109:210-226. 10.1016/j.pharmthera.2005.07.001, 16169595.
5. Kim D, Kim MA, Cho IH, Kim MS, Lee S, Jo EK, Choi SY, Park K, Kim JS, Akira S, et al. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem 2007, 282:14975-14983. 10.1074/jbc.M607277200, 17355971.
6. Martucci C, Trovato AE, Costa B, Borsani E, Franchi S, Magnaghi V, Panerai AE, Rodella LF, Valsecchi AE, Sacerdote P, Colleoni M. The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1beta, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice. Pain 2008, 137:81-95. 10.1016/j.pain.2007.08.017, 17900807.
7. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997, 100:2153-2157. 10.1172/JCI119751, 508409, 9410891.
8. Brown GC, Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 2003, 27:325-355. 10.1385/MN:27:3:325, 12845153.
9. Tieu K, Ischiropoulos H, Przedborski S. Nitric oxide and reactive oxygen species in Parkinson's disease. IUBMB Life 2003, 55:329-335. 10.1080/1521654032000114320, 12938735.
10. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991, 351:714-718. 10.1038/351714a0, 1712077.
11. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992, 89:6348-6352. 10.1073/pnas.89.14.6348, 49498, 1378626.
12. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 1992, 90:2092-2096. 10.1172/JCI116092, 443276, 1385480.
13. Naik AK, Tandan SK, Kumar D, Dudhgaonkar SP. Nitric oxide and its modulators in chronic constriction injury-induced neuropathic pain in rats. Eur J Pharmacol 2006, 530:59-69. 10.1016/j.ejphar.2005.11.029, 16364289.
14. Lee DH, Singh JP, Lodge D. Experiments with nitric oxide synthase inhibitors in spinal nerve ligated rats provide no evidence of a role for nitric oxide in neuropathic mechanical allodynia. Neurosci Lett 2005, 385:179-183. 10.1016/j.neulet.2005.05.036, 15964141.
15. Guan Y, Yaster M, Raja SN, Tao YX. Genetic knockout and pharmacologic inhibition of neuronal nitric oxide synthase attenuate nerve injury-induced mechanical hypersensitivity in mice. Mol Pain 2007, 3:29. 10.1186/1744-8069-3-29, 2089056, 17922909.
16. Mabuchi T, Matsumura S, Okuda-Ashitaka E, Kitano T, Kojima H, Nagano T, Minami T, Ito S. Attenuation of neuropathic pain by the nociceptin/orphanin FQ antagonist JTC-801 is mediated by inhibition of nitric oxide production. Eur J Neurosci 2003, 17:1384-1392. 10.1046/j.1460-9568.2003.02575.x, 12713641.
17. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994, 91:5212-5216. 10.1073/pnas.91.11.5212, 43962, 7515189.
18. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994, 269:13725-13728.
19. Boettger MK, Uceyler N, Zelenka M, Schmitt A, Reif A, Chen Y, Sommer C. Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice. Eur J Pain 2007, 11:810-818. 10.1016/j.ejpain.2006.12.008, 17395508.
20. Morishita T, Tsutsui M, Shimokawa H, Sabanai K, Tasaki H, Suda O, Nakata S, Tanimoto A, Wang KY, Ueta Y, et al. Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. Proc Natl Acad Sci USA 2005, 102:10616-10621. 10.1073/pnas.0502236102, 1175830, 16024729.
21. Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003, 424:778-783. 10.1038/nature01786, 12917686.
22. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438:1017-1021. 10.1038/nature04223, 16355225.
23. Tsuda M, Tozaki-Saitoh H, Masuda T, Toyomitsu E, Tezuka T, Yamamoto T, Inoue K. Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury. Glia 2008, 56:50-58. 10.1002/glia.20591, 17918263.
24. Tsuda M, Masuda T, Kitano J, Shimoyama H, Tozaki-Saitoh H, Inoue K. IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc Natl Acad Sci USA 2009, 106:8032-8037. 10.1073/pnas.0810420106, 2683100, 19380717.
25. Ohsawa K, Imai Y, Nakajima K, Kohsaka S. Generation and characterization of a microglial cell line, MG5, derived from a p53-deficient mouse. Glia 1997, 21:285-298. 10.1002/(SICI)1098-1136(199711)21:3<285::AID-GLIA4>3.0.CO;2-4, 9383038.
26. Doursout MF, Liang Y, Chelly JE. NOS inhibitors exhibit antinociceptive properties in the rat formalin test. Can J Anaesth 2003, 50:909-916. 10.1007/BF03018738, 14617588.
27. Kolesnikov YA, Chereshnev I, Criesta M, Pan YX, Pasternak GW. Opposing actions of neuronal nitric oxide synthase isoforms in formalin-induced pain in mice. Brain Res 2009, 1289:14-21. 2730432, 19545548.
28. Larson AA, Kovacs KJ, Cooper JC, Kitto KF. Transient changes in the synthesis of nitric oxide result in long-term as well as short-term changes in acetic acid-induced writhing in mice. Pain 2000, 86:103-111. 10.1016/S0304-3959(00)00236-0, 10779667.
29. Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 2003, 306:624-630. 10.1124/jpet.103.052407, 12734393.
30. Guasti L, Richardson D, Jhaveri M, Eldeeb K, Barrett D, Elphick MR, Alexander SP, Kendall D, Michael GJ, Chapman V. Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain. Mol Pain 2009, 5:35. 10.1186/1744-8069-5-35, 2719614, 19570201.
31. Dempke W, Zippel R. SRC kinases in tumor therapy. Med Klin (Munich) 105:711-715.
32. Arruda JL, Sweitzer S, Rutkowski MD, DeLeo JA. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain. Brain Res 2000, 879:216-225. 10.1016/S0006-8993(00)02807-9, 11011025.
33. Gordh T, Sharma HS, Alm P, Westman J. Spinal nerve lesion induces upregulation of neuronal nitric oxide synthase in the spinal cord. An immunohistochemical investigation in the rat. Amino Acids 1998, 14:105-112. 10.1007/BF01345250, 9871449.
34. Cizkova D, Lukacova N, Marsala M, Marsala J. Neuropathic pain is associated with alterations of nitric oxide synthase immunoreactivity and catalytic activity in dorsal root ganglia and spinal dorsal horn. Brain Res Bull 2002, 58:161-171. 10.1016/S0361-9230(02)00761-X, 12127013.
35. Levy D, Tal M, Hoke A, Zochodne DW. Transient action of the endothelial constitutive nitric oxide synthase (ecNOS) mediates the development of thermal hypersensitivity following peripheral nerve injury. Eur J Neurosci 2000, 12:2323-2332. 10.1046/j.1460-9568.2000.00129.x, 10947811.
36. Tsuda M, Kuboyama K, Inoue T, Nagata K, Tozaki-Saitoh H, Inoue K. Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays. Mol Pain 2009, 5:28. 10.1186/1744-8069-5-28, 2704200, 19515262.
37. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55-63. 10.1016/0165-0270(94)90144-9, 7990513.
38. Dixon WJ. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980, 20:441-462. 10.1146/annurev.pa.20.040180.002301, 7387124.
39. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50:355-363. 10.1016/0304-3959(92)90041-9, 1333581.
40. Kuboyama K, Harada H, Tozaki-Saitoh H, Tsuda M, Ushijima K, Inoue K. Astrocytic P2Y(1) receptor is involved in the regulation of cytokine/chemokine transcription and cerebral damage in a rat model of cerebral ischemia. J Cereb Blood Flow Metab 2011,